BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29781094)

  • 21. [Risk factors for non-sentinel lymph node metastasis in patients after neoadjuvant chemotherapy].
    Yang Y; He Y; Li J; Xie Y; Wang T; Fan Z; Fan T; Ouyang T
    Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(34):2661-4. PubMed ID: 25511592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer.
    Ramjeesingh R; Quan ML; Gardner S; Holloway CM
    Can J Surg; 2009 Feb; 52(1):23-30. PubMed ID: 19234648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrometastasis, micrometastasis, and isolated tumor cells in sentinel lymph nodes of early breast cancers: a 10-year histopathological and survival analysis of 537 Asian patients.
    Co M; Kwong A
    World J Surg; 2015 Jun; 39(6):1438-42. PubMed ID: 25651960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
    Moo TA; Edelweiss M; Hajiyeva S; Stempel M; Raiss M; Zabor EC; Barrio A; Morrow M
    Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
    Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
    Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.
    Barron AU; Hoskin TL; Boughey JC
    Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors of non-sentinel lymph node metastasis in 443 breast cancer patients with sentinel lymph node-positive.
    Cai SL; Wei RM; Han L; Chen XG; Gong GX; Lin XQ; Zhang J; Chen HD
    Medicine (Baltimore); 2022 Jul; 101(29):e29286. PubMed ID: 35866760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma.
    Chua B; Ung O; Taylor R; Bilous M; Salisbury E; Boyages J
    Cancer; 2001 Oct; 92(7):1769-74. PubMed ID: 11745248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
    Azghadi S; Daly M; Mayadev J
    Clin Breast Cancer; 2016 Oct; 16(5):410-417.e3. PubMed ID: 27266803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy.
    Viale G; Maiorano E; Pruneri G; Mastropasqua MG; Valentini S; Galimberti V; Zurrida S; Maisonneuve P; Paganelli G; Mazzarol G
    Ann Surg; 2005 Feb; 241(2):319-25. PubMed ID: 15650643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Nonsentinel Lymph Node Metastasis in Breast Cancer: A Multicenter Retrospective Study.
    Mikami Y; Yamada A; Suzuki C; Adachi S; Harada F; Yamamoto S; Shimada K; Sugae S; Narui K; Chishima T; Ishikawa T; Ichikawa Y; Endo I
    J Surg Res; 2021 Aug; 264():45-50. PubMed ID: 33752166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
    Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
    J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes.
    Yang L; Zhao X; Yang L; Chang Y; Cao C; Li X; Wang Q; Song Z
    Sci Rep; 2024 Apr; 14(1):9596. PubMed ID: 38671007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.